ThruFlo Endovascular completes seed financing to advance development of its novel bifurcated flow diverter for the treatment of bifurcation aneurysms.
Tag: ThruFlo Endovascular
Recent
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
ThruFlo Endovascular Secures Seed Funding to Advance First Purpose-Built Flow Diverter for Bifurcation Aneurysms
Popular
- No commented posts yet